APA (7th ed.) Citation

Straube, A., Broessner, G., Gaul, C., Hamann, X., Hipp, J., Kraya, T., & Neeb, L. (2023). Real-world effectiveness of fremanezumab in patients with migraine switching from another mAb targeting the CGRP pathway: A subgroup analysis of the Finesse Study. BMC.

Chicago Style (17th ed.) Citation

Straube, Andreas, Gregor Broessner, Charly Gaul, Xenia Hamann, Joachim Hipp, Torsten Kraya, and Lars Neeb. Real-world Effectiveness of Fremanezumab in Patients with Migraine Switching From another MAb Targeting the CGRP Pathway: A Subgroup Analysis of the Finesse Study. BMC, 2023.

MLA (9th ed.) Citation

Straube, Andreas, et al. Real-world Effectiveness of Fremanezumab in Patients with Migraine Switching From another MAb Targeting the CGRP Pathway: A Subgroup Analysis of the Finesse Study. BMC, 2023.